Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT - ASSETS

3 Months Ended

Mar. 31, 2023

NOTE 4 — SELECTED FINANCIAL STATEMENT — ASSETS

Inventories consisted of the following (in thousands):


	March 31, 2023			December 31, 2022
Raw materials and components	$	1,362		$	1,393
Work-in-process		280			513
Finished goods		5,526			5,428
Inventory reserve		(4,952	)		(4,955	)
Total inventories, net	$	2,216		$	2,379

Prepaid expenses and other current assets consisted of the following (in thousands):


	March 31, 2023		December 31, 2022
Prepaid insurance	$	404	$	598
Prepaid expenses		419		467
Other current assets		401		449
Total prepaid expenses and other current assets	$	1,224	$	1,514

Property and equipment consisted of the following (in thousands):


	March 31, 2023			December 31, 2022
Equipment	$	373		$	367
Leasehold improvements		39			39
Furniture and fixtures		99			99
Total property and equipment		511			505
Less: accumulated depreciation		(439	)		(430	)
Total property and equipment, net	$	72		$	75

During the three months ended March 31, 2023 and 2022, depreciation expense was approximately $9,000 and $11,000, respectively.